Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > Commercialisation

Translation and Commercialisation

Our translation and commercialisation office works closely with Centenary scientists to progress research discoveries towards the development of new treatments. Centenary actively engages with pharmaceutical and biotech companies, investors and other academic collaborators globally.

BREAKTHROUGHS

Innovations

Centenary strives to deliver improved health outcomes to patients. Centenary’s research expertise, capabilities and discoveries span a wide range of areas and indications. 

Centre: Healthy Ageing

Indication: Alzheimer’s disease

Stage: Preclinical

Description: Therapy targeting a novel mechanism

Status: Licensed.  Open to investment.

Centre: Infection & Immunity

Indication: COVID

Stage: Preclinical

Description: Novel composition and formulation

Status: Available to licence

Centre: Cancer Innovations

Indication: Diagnostic – aggressive cancers

Stage: Phase 1

Description: A novel tumour imaging agent for rapid assessment of treatment response

Status: Licensed

Centre: Rare Diseases & Gene Therapy

Indication: Genetic diseases

Stage: Preclinical

Description: Platform technology to increase efficiency and safety, and reduce cost of AAV gene therapies

Status: Available for licensing or investment via start-up AAVec Bio

Centre: Biomedical AI

Indication: Broad application

Stage:

Description: Directed evolution system to rapidly optimise selected properties of biologics

Status: Seeking collaborations

Centre: Rare Diseases & Gene Therapy

Indication: Broad application

Stage:

Description: Direct & quantifiable measurement of small molecule-target engagement

Status: Seeking collaborations

Centre: Cancer Innovations

Indication: Aggressive Cancers

Stage: Preclinical

Description: A novel radiotherapy for aggressive cancers

Status: Licensed

Centre: Infection & Immunity

Indication: Tuberculosis

Stage: Preclinical

Description: Novel compositions. Large head-2-head study of a range of antigens & adjuvants to select optimal composition

Status: Seeking investment

Research Journeys

  • Blood fats predict success of dietary weight loss in pre-diabetes management

    New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalised approaches to preventing and managing type 2 diabetes.
  • New genetic tool predicts risk of liver disease in heavy drinkers

    An international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at risk of developing alcohol-associated cirrhosis, a severe form of liver disease.
  • New technology, ‘Invasion-Block’, targets melanoma spread

    Research conducted at the Centenary Institute has given rise to a ground-breaking tool called ‘Invasion-Block’ that can identify drugs capable of halting the spread of cancer cells. The pioneering development could lead to better treatments for melanoma, the most dangerous form of skin cancer.

Contact

For enquires, contact: 

Dr Katrina Frankcombe

Translation and Commercialisation Manager

Email: k.frankcombe@centenary.org.au

Phone: 02 9565 6266

EMAIL

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram